US 10093745
Anti-CSPG4 fusions with interferon for the treatment of malignancy
granted A61KA61K2039/505A61K38/212
Quick answer
US patent 10093745 (Anti-CSPG4 fusions with interferon for the treatment of malignancy) held by The Regents of the University of California expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61K38/212, A61K38/215, A61K38/217